iCAD, Inc. Announces Information Related to Reimbursement

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
iCAD, Inc. Announces Information Related to Reimbursement Levels

NASHUA, N.H., May 6, 2015 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq: ICAD ) announced today that Noridian, the Medicare Administrative Contractor in Jurisdictions E and F, which consists of 13 states primarily on the West Coast, has made recent web postings related to Coding for High Dose Rate Brachytherapy for Non-Melanoma Skin Cancers which instruct physicians to report CPT code (17999) rather than the established CPT code (0182T) for electronic brachytherapy for non-melanoma skin cancers. The Company, industry partners and physician providers have reached out to the Centers for Medicare and Medicaid Services ("CMS") and Noridian to seek clarification of the Medicare Coverage Articles posted to Noridian's web sites.

The Company is proactively addressing the situation in its dialogue with Noridian and CMS. At this point, there is insufficient clarification of the reimbursement matter to assess the potential impact that this matter could have on the Company's guidance for 2015. Any significant changes in CPT reimbursement from current levels could have a material impact on the Company's revenues.

About iCAD, Inc.

iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster while improving patient outcomes. iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers. iCAD's Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a painless, non-invasive technology that delivers high dose rate, low energy radiation, which targets cancer while minimizing exposure to surrounding healthy tissue. The Xoft System is FDA cleared and CE marked for use anywhere in the body, including treatment of non-melanoma skin cancer, early-stage breast cancer and gynecological cancers. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection and radiation therapy treatments. For more information, visit www.icadmed.com or www.xoftinc.com .

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

Certain statements contained in this News Release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to the Company's ability to defend itself in litigation matters, to achieve business and strategic objectives, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, uncertainty of future sales levels, protection of patents and other proprietary rights, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence of products, increased competition, litigation and/or government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company; and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "will", "continue", "anticipate", "likely", "seek", and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at http://www.icadmed.com and on the SEC's website at http://www.sec.gov .

For iCAD investor relations: The Ruth Group Zack Kubow / Courtney Dugan 646-536-7020 / 7024

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fall Pest Risks Linger as Mild Weather Extends Threat

Updated Category News Views 125

A cold snap is not a magic off switch for mosquitoes, ticks, or rodents, and that is the sober point behind the National Pest Management Association's fall and winter 2026 Public Health Pest Index. The group is flagging conditions, not predicting that every household in a named city will face an infestation or illness. Still, mild temperatures, rain, flooding, and plenty...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 0

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 223

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
LGT Middle East Win Highlights Patient Private Banking

Updated Category News Views 20

A trophy in Dubai is not a balance sheet, but it can be a useful calling card when the clientele measures relationships in decades rather than quarters. LGT Middle East was named Best Pure Play Private Bank at the WealthBriefing MENA Awards 2026, at a ceremony held in Dubai on November 18. For a family-owned wealth manager working with Middle Eastern families, that sort...

Continue Reading
T. Rowe Price Expands Teams Across 12 Fund Strategies

Updated Category News Views 0

A Quiet Personnel Shift With Real Stakes Twelve strategy changes may sound like administrative wallpaper, but asset managers live and die by who makes the calls. T. Rowe Price is broadening portfolio-management teams across equity and fixed-income offerings while insisting that each strategy's philosophy, process, and risk limits remain intact. Fine. That is the stated...

Continue Reading
CustomerInsights.AI Fast 500 Nod Tests Its AI Model

Updated Category News Views 0

Pharma’s analytics mess is exactly where CustomerInsights.AI has chosen to make its stand. The Scottsdale company’s inclusion in Deloitte’s 2026 Technology Fast 500, announced November 19, is a useful signal that its pitch is finding buyers: life-sciences businesses want AI to do actual commercial work, not sit in a lab demo collecting dust. Still, a Fast 500 badge...

Continue Reading
Blue Diamond's $1 Billion Brand Meets Farm Realities

Updated Category News Views 118

A Ten-Cent Signal Carries Real Weight A ten-cent edge over the industry benchmark may not excite the cocktail-party crowd, but almond growers notice every penny when fertilizer, power and pest control keep gnawing at the farm gate. Blue Diamond Growers says it delivered payments roughly 10 cents above the benchmark in its latest year, alongside net profit that came in...

Continue Reading
MSD's AI Drug Bet Has Promise, but Plenty to Prove

Updated Category News Views 40

A promising molecule remains a very expensive guess until biology agrees. That is the sober lens for MSD's newly announced research collaboration with Isomorphic Labs: potentially meaningful science, certainly interesting strategic positioning, and absolutely no reason yet to start penciling in product sales. One Oncology Target, Not a Finished Drug On November 19, 2026,...

Continue Reading
ROBOTERA Puts Humanoid Robots Into Logistics Night Work

Updated Category News Views 0

Midnight warehouse work is where a humanoid robot has to quit posing and earn its keep. ROBOTERA arrived at the 2026 APEC CEO Summit with a useful answer to the usual shiny-robot nonsense: it says its machines are already working in logistics centers, handling parcel induction and taking on repetitive, physically demanding shifts that people understandably do not line up...

Continue Reading
Circuit Adds Gabe Klein as Microtransit Expansion Adviser

Updated Category News Views 189

Municipal mobility is a slow, political grind, not a shiny-app contest, and Circuit’s decision to add Gabe Klein to its board looks aimed squarely at that reality. The all-electric microtransit operator has brought aboard somebody who has worked inside the machinery of city government, federal transportation policy, electrification, venture investing, and transportation...

Continue Reading

Top 5 Most Recently Viewed Articles

Clipper Realty Inc. Announces Upcoming Third Quarter Report

Updated Category News Views 40

Clipper Realty Inc. Announces Financial Results Release Clipper Realty Inc. (NYSE: CLPR), a distinguished owner and operator of multifamily residential and commercial properties, is gearing up to share its financial performance for the third quarter of 2024. The report will be disclosed after market hours, providing a comprehensive look at the company's financial health....

Continue Reading
Nvidia's Strategic Moves in China May Boost Stock Value

Updated Category News Views 156

Nvidia's Strategic Moves May Boost Investor Confidence Analyst N. Quinn Bolton has recently reaffirmed his Buy rating on Nvidia (NASDAQ: NVDA) while also increasing the price target from $160 to $200. This optimistic projection suggests significant growth potential for Nvidia's stock as it prepares to re-enter a key market. Resuming Shipments of H20 GPUs Nvidia has...

Continue Reading
Strategic Changes in Boliden's Governance Ahead of 2026 AGM

Updated Category News Views 156

Introduction to Boliden's Governance Changes In a significant move to enhance governance, Boliden AB, a leading metals company, has restructured its Nomination Committee ahead of the upcoming Annual General Meeting (AGM) scheduled for 2026. The new framework emphasizes a collaborative approach by involving the company's largest shareholders, ensuring their voices are...

Continue Reading
Influence of Peter Thiel and Elon Musk on Governance

Updated Category News Views 1523

The Influence of Peter Thiel and Elon Musk on Governance The billionaire entrepreneur Peter Thiel wields considerable influence despite not holding an official position within the government. His affiliations with a variety of organizations committed to government reform have led him to be an important figure in contemporary political discourse. Connections to the Trump...

Continue Reading
Biden Administration's Import Regulations Impact E-Commerce Stocks

Updated Category News Views 102

Concerns About New Import Regulations Shares of major Chinese e-commerce companies, such as JD.com (NASDAQ: JD), Alibaba (NYSE: BABA), and Pinduoduo (NASDAQ: PDD), saw a noticeable drop in premarket trading. This decline followed a report suggesting that the Biden administration plans to toughen regulations on low-value imports. Effects on Key Players in E-Commerce...

Continue Reading